The EUROclass trial: defining subgroups in common variable immunodeficiencyClaudia Wehr, Klaus Warnatz, Philip R. Bos et al.|Blood|2007Cited by 860
Performance of mutation pathogenicity prediction methods on missense variantsJanita Thusberg, Mauno Vihinen|Human Mutation|2011Cited by 542
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Jennifer R. Brown, Filippo Utro et al.|Blood Advances|2022Cited by 79
Site-Directed Mutagenesis of a Thermostable α-Amylase from Bacillus stearothermophilus: Putative Role of Three Conserved Residues1Mauno Vihinen, Pekka Mänstsälä, Pauli Olikka et al.|The Journal of Biochemistry|1990Cited by 73